• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Engineered CAR Dendritic Cells Suppress Tumor Growth in Mouse Models

by
November 13, 2026
in Biology
Reading Time: 2 mins read
0
Engineered CAR Dendritic Cells Suppress Tumor Growth in Mouse Models

Engineered CAR Dendritic Cells Suppress Tumor Growth in Mouse Models

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Chimeric antigen receptor-engineered dendritic cells incorporating endocytic receptor intracellular domains prime T cells and suppress tumor growth in preclinical mouse models, according to a study published in Nature Immunology. While dendritic cells serve as central orchestrators of antitumor immunity, their therapeutic effectiveness in solid tumors has been limited by cellular dysfunction and inadequate activation. To address these constraints, researchers engineered chimeric antigen receptor dendritic cells, or CAR-DCs, using specific intracellular signaling domains to enhance dendritic cell activity and reprogram the immunosuppressive tumor microenvironment.

The investigators identified the intracellular domains of the endocytic receptors CLEC9A and LY75, also known as DEC205, as essential elements for functional CAR-DC activity. Incorporating the intracellular domains of CLEC9A or DEC205 into CAR constructs triggered spleen tyrosine kinase phosphorylation and initiated downstream intracellular signaling. This signaling cascade promoted cellular uptake of antigens and enhanced antigen cross-presentation, which subsequently drove the expansion and functional activation of T cells.

In vivo evaluations across conventional and humanized mouse models demonstrated that CAR-DC administration suppressed solid tumor growth. The engineered dendritic cells promoted the expansion of tumor-reactive T cells, cross-presenting tumor antigens to stimulate CD8-positive T cell-mediated tumor killing. The treatment altered cell-to-cell interactions, remodeled the surrounding tumor microenvironment, and maintained a favorable preclinical safety profile in the tested animal models.

The authors also demonstrated that human HER2-targeted DEC205 and CLEC9A CAR-DCs mediated effective antitumor responses in experimental models. Based on these observations in cell and animal systems, the authors concluded that CAR-DCs provide a scalable and clinically translatable platform for solid tumor immunotherapy, though clinical benefits in human patients remain to be investigated in future clinical trials.

Subject of Research: Chimeric antigen receptor-engineered dendritic cells for solid tumor immunotherapy

Article Title: Rewiring dendritic cell function with CLEC9A and DEC205 CARs

Article References: Niu, C., Dai, X., Gao, H., Zhang, H., Ma, Y., Wang, H., Xiao, Z., Xu, Y., He, S., Ye, Z., Tang, X., Lin, P., Li, K., Pittet, M. J., Zhang, L., & Wang, C. (2026). Rewiring dendritic cell function with CLEC9A and DEC205 CARs. Nature Immunology. https://doi.org/10.1038/s41590-026-02711-3

Image Credits: AI Generated

DOI: 10.1038/s41590-026-02711-3

Keywords: dendritic cells, chimeric antigen receptors, CAR-DCs, CLEC9A, DEC205, LY75, SYK phosphorylation, antigen cross-presentation, CD8+ T cells, tumor microenvironment, solid tumors, humanized mice, HER2, cancer immunotherapy, T cell proliferation, antitumor immunity

News Source: Nathaniel Bowman. (November 13, 2026). Engineered CAR Dendritic Cells Suppress Tumor Growth in Mouse Models. Scienmag.

Tags: antigen cross-presentationantitumor immunityCancer immunotherapyCAR-DCsCD8+ T cellschimeric antigen receptorsCLEC9ADEC205dendritic cellsHER2humanized miceLY75solid tumorsSYK phosphorylationT cell proliferationtumor microenvironment
Share12Tweet7Share2ShareShareShare1

Related Posts

Genetically Predicted CXCL16 Expression Linked to Elevated Parkinson's Disease Risk

Genetically Predicted CXCL16 Expression Linked to Elevated Parkinson’s Disease Risk

November 19, 2026
Deep Learning Accurately Automates Nottingham Histological Grading in Canine Mammary Cancer

Deep Learning Accurately Automates Nottingham Histological Grading in Canine Mammary Cancer

November 19, 2026

Precision Base Editing Advances Genetic Improvement in Livestock and Aquaculture

November 19, 2026

Review Examines How BRCA1 Loss May Drive Luminal Cells Toward Basal Cancer

November 19, 2026

POPULAR NEWS

  • Engineered CAR Natural Killer Cells Target Mesothelin in Ovarian Cancer Models

    Engineered CAR Natural Killer Cells Target Mesothelin in Ovarian Cancer Models

    29 shares
    Share 12 Tweet 7
  • Industrial Winemaking Enzyme Cocktail Enables High Efficiency Genetic Transformation in Medicinal Mushrooms

    29 shares
    Share 12 Tweet 7
  • Infantile Case Report Links Novel NAXE Gene Variant to Fatal Encephalopathy

    29 shares
    Share 12 Tweet 7
  • Inherited Genetic Variants Significantly Shape Glioma Risk and Tumor Biology

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Human Lung Chip Models Severe Influenza Injury and Secondary Bacterial Superinfection

Genetically Predicted CXCL16 Expression Linked to Elevated Parkinson’s Disease Risk

Deep Learning Accurately Automates Nottingham Histological Grading in Canine Mammary Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.